New obesity drug KAI-9531 aims to outperform semaglutide in major trial

NCT ID NCT07284979

Recruiting now Disease control Sponsor: Kailera Source: ClinicalTrials.gov ↗

First seen Jan 02, 2026 · Last updated May 24, 2026 · Updated 19 times

Summary

This study tests a new weekly injection, KAI-9531, to see if it helps people with obesity lose more weight than the existing drug semaglutide or a placebo. About 1,200 adults with a BMI of 35 or higher who have tried to lose weight before will take part. The main goal is to measure weight change over 76 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Kailera Clinical Site
RECRUITING

Glendale, Arizona, 85308, United States
Kailera Clinical Site
RECRUITING

Phoenix, Arizona, 85012, United States
Kailera Clinical Site
RECRUITING

Little Rock, Arkansas, 72205, United States
Kailera Clinical Site
RECRUITING

Northridge, California, 91325, United States
Kailera Clinical Site
RECRUITING

Oceanside, California, 92058, United States
Kailera Clinical Site
RECRUITING

Hamden, Connecticut, 06517, United States
Kailera Clinical Site
RECRUITING

Stamford, Connecticut, 06905, United States
Kailera Clinical Site
RECRUITING

Orange City, Florida, 32763, United States
Kailera Clinical Site
RECRUITING

Albany, Georgia, 31707, United States
Kailera Clinical Site
RECRUITING

Chicago, Illinois, 60640, United States
Kailera Clinical Site
RECRUITING

Newton, Kansas, 67114, United States
Kailera Clinical Site
RECRUITING

Shreveport, Louisiana, 71105, United States
Kailera Clinical Site
RECRUITING

Farmington Hills, Michigan, 48334, United States
Kailera Clinical Site
RECRUITING

Missoula, Montana, 59804, United States
Kailera Clinical Site
RECRUITING

Las Vegas, Nevada, 89148, United States
Kailera Clinical Site
RECRUITING

Albany, New York, 12203, United States
Kailera Clinical Site
RECRUITING

Morehead City, North Carolina, 28557, United States
Kailera Clinical Site
RECRUITING

Norman, Oklahoma, 73069, United States
Kailera Clinical Site
RECRUITING

East Greenwich, Rhode Island, 02818, United States
Kailera Clinical Site
RECRUITING

North Charleston, South Carolina, 29405, United States
Kailera Clinical Site
RECRUITING

Spartanburg, South Carolina, 29303, United States
Kailera Clinical Site
RECRUITING

Brownsville, Texas, 78526, United States
Kailera Clinical Site
RECRUITING

San Antonio, Texas, 78229, United States
Kailera Clinical Site
RECRUITING

Manassas, Virginia, 20110, United States
Kailera Clinical Site
RECRUITING

Richmond, Virginia, 23236, United States
Kailera Clinical Site
RECRUITING

Bruce, Australian Capital Territory, 2617, Australia
Kailera Clinical Site
RECRUITING

Blacktown, New South Wales, 2148, Australia
Kailera Clinical Site
RECRUITING

Kanwal, New South Wales, 2259, Australia
Kailera Clinical Site
RECRUITING

Herston, Queensland, 4006, Australia
Kailera Clinical Site
RECRUITING

Morayfield, Queensland, 4506, Australia
Kailera Clinical Site
RECRUITING

South Brisbane, Queensland, 4101, Australia
Kailera Clinical Site
RECRUITING

Camberwell, Victoria, 3124, Australia

Conditions

Explore the condition pages connected to this study.

OBESITY